Deferred Income Tax Expense (Benefit) in USD of Klotho Neurosciences, Inc. from 2022 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Klotho Neurosciences, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2022 to Q1 2023.
  • Klotho Neurosciences, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $94.8K.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), Annual (USD)

Klotho Neurosciences, Inc. Quarterly Deferred Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $94.8K Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-24

Klotho Neurosciences, Inc. Annual Deferred Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $79K Jan 1, 2022 Dec 31, 2022 10-K/A 2023-10-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.